Stay updated on BA3071 in PD-1 Combo for Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the BA3071 in PD-1 Combo for Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BA3071 in PD-1 Combo for Solid Tumors Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-10-02T23:49:43.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A new Phase 1/2 study of BA3071 in patients with solid tumors has been added, focusing on a combination therapy with chemotherapy, while a previous study involving BA3071 as monotherapy and in combination with a PD-1 blocking antibody has been removed.
    Difference
    8%
    Check dated 2024-09-25T17:04:56.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.1%
    Check dated 2024-09-04T03:59:38.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    A new Phase 1/2 study of BA3071 is now enrolling patients with nonsquamous or recurrent NSCLC and melanoma, focusing on specific genetic mutations, while a previous study involving advanced solid tumors has been removed.
    Difference
    22%
    Check dated 2024-08-13T22:28:20.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2024-08-06T21:28:34.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-07-30T21:27:21.000Z thumbnail image

Stay in the know with updates to BA3071 in PD-1 Combo for Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BA3071 in PD-1 Combo for Solid Tumors Clinical Trial page.